🚩 On the watch list, its certificate can't be verified in its own name.
Crownpeptides openly does its testing 'in-house', i.e. the company selling the product also writes the certificate that says the product is good. There is no outside check anywhere in that loop; the purity figure is whatever they decide to print. Calling that a 'Certificate of Analysis' borrows the authority of independent testing while removing the one thing that gives it meaning, independence. Aggravating: runs contact/orders through WhatsApp.
The certificate, and what's wrong with it
What this certificate actually is: An in-house 'certificate', the seller testing its own product. There is no independent lab here.
⏳ This certificate is dated Oct 2023, about 2 years old. A certificate from Oct 2023 cannot describe anything this seller would ship you today, that batch is long gone. Showing a about 2 years old certificate for a product on sale now is meaningless; the stock you'd actually receive is untested.
Pricing vs the market, benchmarked on BPC-157
BPC-157
£29.5/mg (≈ £294.99 for a 10 mg vial)
Versus market median (£3.0/mg)
9.8×, extreme outlier
Wildly overpriced versus the market. The Peptide Watch benchmarks every vendor on the same compound, BPC-157, the most common research peptide, as £ per milligram, so prices are directly comparable across all providers.
The audit checklist
Check
Result
Verifiable certificate in its own name
No
Independent lab named
None named / unverifiable
Tests its own stock
No evidence
Pricing vs market
9.8× median (extreme outlier)
The bottom line. Crownpeptides sits on the watch list because it does not publish a certificate that can be verified in its own name. Everything above is observable on its own website and the public record. See the vendors whose certificates are actually their own →
⚠️ Is anything on this page wrong or out of date? Submit a correction request and we'll look into it, vendors welcome too.